ECP 2023 Final Programme

Poster Sessions a Sunday 82 Sunday, 10 Sept PS-01 e Sunday, 10 September 2023 PS-01 Poster Session 09:30–10:30 The Forum Poster Session Breast Pathology Chairs: Anikó Kovács, Sweden Giuseppe Floris, Belgium 001 Inter-laboratory variability of HER2-low analysis using Artificial Intelligence Nils ‘t Hart, The Netherlands M. Eenkhoorn, H. Høeg, D. Dabbs 002 Androgen receptor mRNA is associated with better survival outcomes in triple negative breast cancer Syed Salahuddin Ahmed, Singapore D. Lee, C. Ong, B. Lee, J. Yeong, J. Iqbal 003 Ki67 quantitation in breast cancer: a comparative analysis of four counting methods Constance Albarracin, USA Y. Wu, M. Mersereau, H. Chen 004 Concordance of Nottingham histologic and neuroendocrine grading schemes in mammary neuroendocrine neoplasms Constance Albarracin, USA J. Wen, K. Sweeney, Q. Ding, Y. Wu 005 TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin Szintia Almási, Hungary L. Kuthi, A. Sejben, A. Voros, Á. Nagy, T. Zombori, G. Cserni 006 NGS mutational status on first diagnostic tissue and liquid biopsy in breast cancer Carmen Maria Ardeleanu, Romania M. Olinca, B. Galateanu, H. Muresan, A. Tecuceanu Vulpe, I. Gune, G. Manole, M. Bugeanu, A. Hudita 007 Successful deployment of an artificial intelligence solution for primary diagnosis of breast biopsies in clinical practice Anu Gunavardhan, United Kingdom M. Aslam, A. Gunavardhan, A. Phillips, A. Savage, P. Huey, R. Nicholson, I. Krasnitsky, D. Ignatov, M. Grinwald, M. Vecsler 008 Impact of analytic factors of immunohisto- chemistry (IHC) on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer Young Kyung Bae, Korea S. Kwon, M. Kim 009 HER2-low breast cancer and response to neoadjuvant chemotherapy: a popula- tion-based cohort study Ximena Baez Navarro, The Netherlands C. van Deurzen, M. van Bockstal 010 Alteration of HER2 status during metastatic progression of breast cancer in the HER2-low population Kyungah Bai, Korea H. Kwon, K. Suh, S. Kim, J. Kim, S. Park 012 CD47 and CD68 expression in breast cancer is associated with tumour-infiltrating lymphocytes, blood vessel invasion, detection mode and prognosis Ying Chen, Norway T. Klingen, H. Aas, E. Wik, L. Akslen 013 The importance of establishing ground truth when building clinical-grade artificial intelligence tools for breast cancer Catherine Conway, USA S. Ali Arshad, P. Khorramshahi, H. Eslami Manoochehri, D. Miller, J. Wang, R. Millican-Slater, A. Hanby, J. Stephenson, D. Bansal, C. Colquhoun, A. Wright, O. Colgan, D. Treanor, C. Salinas 014 Cytological features of breast ductal adenoma Francesco Di Donato, Italy M. Cattani, A. Tafa’, M. Cucchi, L. Saragoni, M. Foschini